Doctor profile · Federal record
Dr. ANISH NANAVATI
Hematology & Oncology Physician (CMS: INTERNAL MEDICINE) · WALDORF, MD
- NPI 1154582989
- Accepts Medicare
- MIPS 77.5 / 100 · 2023
- 18 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
10 SAINT PATRICKS DR FL 1
WALDORF, MD 206034527
(301) 645-4242
fax (301) 705-7512
Credentials & registration
- NPI registered
- June 2008 — 18 yrs on file
- Profile last updated
- July 22, 2021
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Maryland #D0079889
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1154582989. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
34,760
Distinct HCPCS
10
Medicare allowed
$371,811
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9267 |
Injection, paclitaxel, 1 mg | 11,089 | 12 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 9,800 | 15 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 5,320 | 32 | $0 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 1,112 | 13 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 924 | 356 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 787 | 398 | $91 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 760 | 19 | $1 | |
96375 |
Injection of additional new drug or substance into vein | 741 | 39 | $16 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 686 | 281 | $128 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 483 | 138 | $8 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 3,492. This provider delivers 10.0× the peer median.Open Payments
Industry payments received
All-time total
$1,247
Transactions
32
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Celgene Corporation | 4 | $293.17 | |
| Janssen Biotech, Inc. | 8 | $192.10 | |
| Medtronic, Inc. | 1 | $138.66 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51.84 | |
| PFIZER INC. | 2 | $47.25 | |
| ABBVIE INC. | 2 | $45.54 | |
| Incyte Corporation | 2 | $40.87 | |
| Astellas Pharma US Inc | 2 | $38.56 | |
| Eisai Inc. | 2 | $36.00 | |
| Novartis Pharmaceuticals Corporation | 1 | $34.67 | |
| PharmaEssentia USA Corporation | 1 | $32.98 | |
| TAIHO ONCOLOGY, INC. | 2 | $29.98 | |
| ADC Therapeutics America, Inc. | 1 | $28.60 | |
| TerSera Therapeutics LLC | 1 | $28.23 | |
| Stemline Therapeutics Inc. | 1 | $27.18 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
457
Patients
60
Total drug cost
$1,355,156
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 131 | 35 | $5,068 |
| Eliquis (Apixaban) | Brand | 68 | 14 | $61,231 |
| Xarelto (Rivaroxaban) | Brand | 35 | 0 | $32,105 |
| Hydroxyurea | Generic | 31 | 0 | $1,022 |
| Lenalidomide | Generic | 24 | 0 | $244,615 |
| Revlimid (Lenalidomide) | Brand | 24 | 0 | $443,090 |
| Ondansetron Hcl | Generic | 23 | 11 | $184 |
| Abiraterone Acetate | Generic | 19 | 0 | $81,068 |
| Letrozole | Generic | 17 | 0 | $774 |
| Prednisone | Generic | 16 | 0 | $145 |